NYSE: HQH - Tekla Healthcare Investors

Lønnsomhet i seks måneder: -6.48%
Sektor: Financials

Kampanjeplan Tekla Healthcare Investors

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.

flere detaljer
It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 1988-01-05
ISIN US87911J1034
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 10.59
Дивиденд ао 1.07
Сайт https://www.teklacap.com/hqh.html
Цена ао 16.69
Prisendring per dag: -0.5438% (16.55)
Prisendring per uke: +1.04% (16.29)
Prisendring per måned: -5.4% (17.4)
Prisendring over 3 måneder: -11.36% (18.57)
Prisendring over seks måneder: -6.48% (17.6)
Prisendring per år: -0.6639% (16.57)
Prisendring over 3 år: -30.14% (23.56)
Prisendring over 5 år: -21.88% (21.07)
Prisendring over 10 år: 0% (16.46)
Prisendring siden begynnelsen av året: -6.48% (17.6)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 13.27 1
P/BV 0.8282 9
P/E 13.69 8
EV/EBITDA 13.69 7
Total: 7.63

Effektivitet

Navn Betydning Karakter
ROA, % 6.04 2
ROE, % 6.05 2
Total: 4.33

Utbytte

Navn Betydning Karakter
Div yield, % 10.3 10
DSI 0.8571 8.57
Total: 6.19

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -140.47 0
Lønnsomhet Ebitda, % -138.77 0
Lønnsomhet EPS, % -132.28 0
Total: 0
Flere detaljer

Institusjoner Volum Dele, %
Morgan Stanley 3021776 6.25
Saba Capital Management, L.P. 1424346 2.95
Cornerstone Advisors, LLC 732299 1.51
AQR Arbitrage LLC 500418 1.03
Royal Bank of Canada 469916 0.97
RPO LLC 382486 0.79
Clough Capital Partners, LP 323228 0.67
BOOTHBAY FUND MANAGEMENT, LLC 312251 0.65
Logan Stone Capital, LLC 297287 0.61
Eschler Asset Management LLP 263560 0.55

ETF Dele, % Lønnsomhet for året, % Utbytte, %
First Trust Income Opportunities ETF 3.34939 18.3 2.48805
Amplify High Income ETF 3.10824 6.94 2.77149
Saba Closed End Funds ETF 2.13068 17.31 2.29022



Veileder Stillingstittel Betaling Fødselsår
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager N/A 1953 (72 år)
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager N/A
Mr. Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager N/A
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager N/A 1962 (63 år)

Adresse: United States, Boston. MA, 100 Federal Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.teklacap.com/hqh.html